Simplex Trading’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-54,500
| Closed | -$2K | – | 10446 |
|
|
2023
Q1 | $2K | Sell |
54,500
-2,400
| -4% | -$23.8K | ﹤0.01% | 8609 |
|
|
2022
Q4 | $567K | Buy |
56,900
+38,900
| +216% | +$290K | ﹤0.01% | 3030 |
|
|
2022
Q3 | $99K | Sell |
18,000
-4,100
| -19% | -$22.7K | ﹤0.01% | 5556 |
|
|
2022
Q2 | $80K | Buy |
22,100
+14,500
| +191% | +$68.5K | ﹤0.01% | 5879 |
|
|
2022
Q1 | $45K | Sell |
7,600
-6,100
| -45% | -$37.2K | ﹤0.01% | 7292 |
|
|
2021
Q4 | $115K | Sell |
13,700
-1,400
| -9% | -$12.2K | ﹤0.01% | 6034 |
|
|
2021
Q3 | $126K | Hold |
15,100
| – | – | ﹤0.01% | 6294 |
|
|
2021
Q2 | $122K | Buy |
15,100
+15,083
| +88,724% | +$103K | ﹤0.01% | 6448 |
|
|
2021
Q1 | $9K | Buy |
+17
| New | +$84 | ﹤0.01% | 7983 |
|
|
2016
Q2 | – | Sell |
-2
| Closed | -$5K | – | 6637 |
|
|
2016
Q1 | $5K | Sell |
2
-1
| -33% | -$14 | ﹤0.01% | 4147 |
|
|
2015
Q4 | $42K | Buy |
+3
| New | +$51 | ﹤0.01% | 2069 |
|
Simplex Trading's APEN Position: Q2 2022 in Review
Simplex Trading sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2022, closing a stake of 8,470 shares — an estimated $40K sold.
Simplex Trading first reported a position in APEN in Q4 2014 and held it in 2 quarters. The position peaked at $51K in Q1 2022. 63 funds tracked by Wall St. Rank hold APEN as of Q2 2022.
- Simplex Trading reported no remaining Apollo Endosurgery, Inc. position as of Q2 2022 after selling out during the quarter.
- Simplex Trading sold 8,470 Apollo Endosurgery, Inc. shares in Q2 2022, an estimated $40K.
- Simplex Trading first reported a position in Apollo Endosurgery, Inc. in Q4 2014 and held it in 2 quarters.
- Simplex Trading's Apollo Endosurgery, Inc. position peaked at $51K in Q1 2022.
- 63 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2022.
Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.